Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA Fluorescence-Guided Surgery in Head and Neck Cancers
NCT05101798Phase 2Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in head and neck cancer (HNC), Skull base tumor, sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2021; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
head and neck cancer (HNC)Skull base tumor
Beyond the preview
Go deeper on NCT05101798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05101798.